Translational results bolster confidence as Phase III trial for IMNN-001 in advance epithelial ovarian cancer gets underway.

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Translational Data from OVATION 2 Trial Presented at AACR Special ...

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), , a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announced the publication of the mechanism ...

Imunon (IMNN) announced the presentation of new positive translational data from the Phase 2 OVATION 2 Study of IMNN-001, its investigational ...

Results from OVATION 2 Study reinforce IMNN-001 efficacy benefits observed in the clinic and unique mechanism of action, producing key ...

People with new-onset type 1 diabetes can achieve similar improvements in C-peptide levels with a 0.5 mg/kg antithymocyte ...

TNF-driven inflammatory arthritis, commonly accompanied by vitamin D deficiency. Here, we investigate the interaction between ...

Researchers evaluated the prevalence of low-level viremia and its influence on the risk for virologic failure in patients with HIV on antiretroviral therapy.

Type 1 diabetes remains a persistent health-care burden despite substantial advances in care. Its preclinical disease course ...

ELI-002 induced mKRAS-specific T cell responses in 99% of evaluable patients (89 of 90) who were treated with the investigational vaccine ...

Immuno-aging score and other hallmarks of aging were raised in patients during early stages of rheumatoid arthritis.

Researchers mapped immune cells from centenarians, their offspring, and younger controls across three cohorts using multi-omics single-cell profiling. They found that centenarians retain leaner helper ...